Compile Data Set for Download or QSAR
Report error Found 79 Enz. Inhib. hit(s) with all data for entry = 11490
TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620523BDBM620523(2-((Bis(3-borono-5-(trifluoromethyl)phenyl)(oxo)-&...)
Affinity DataKd:  6.00E+4nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620519BDBM620519((S)-2,3-Bis(1-hydroxy-4-(trifluoromethyl)-1,3-dihy...)
Affinity DataKd:  2.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620521BDBM620521((3-Borono-5-((3-borono-5-(pentafluoro-λ6-sulf...)
Affinity DataKd:  3.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620507BDBM620507(3-Borono-5-(5-borono-2,4-difluorobenzoyl)benzoic a...)
Affinity DataKd:  3.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620512BDBM620512((3-Borono-5-((3-borono-5-(trifluoromethyl)phenyl)d...)
Affinity DataKd:  4.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620509BDBM620509((S)-2,3-Bis(7-fluoro-1-hydroxy-1,3-dihydrobenzo[c]...)
Affinity DataKd:  5.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620528BDBM620528(2-((Bis(3-borono-5-chlorophenyl)(oxo)-λ6-sulf...)
Affinity DataKd:  6.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620536BDBM620536(4-Borono-2-((3-borono-5-(trifluoromethyl)phenyl)su...)
Affinity DataKd:  7.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620537BDBM620537(2-((Bis(3-borono-5-(trifluoromethoxy)phenyl)(oxo)-...)
Affinity DataKd:  8.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620524BDBM620524(N-(4-(Difluoromethyl)-1-hydroxy-1,3-dihydrobenzo[c...)
Affinity DataKd:  8.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620499BDBM620499(N-(7-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  8.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620506BDBM620506(3-Borono-5-(3-borono-5-fluorobenzoyl)benzoic acid ...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620520BDBM620520(4-((3S,4S)-3,4-Bis(1-hydroxy-4-(trifluoromethyl)-1...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620500BDBM620500(3,5-Bis((7-fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620535BDBM620535(N-(1-Hydroxy-4-((trifluoromethyl)sulfonyl)-1,3-dih...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620517BDBM620517((3-Borono-5-((3-borono-5-fluorophenyl)sulfonyl)ben...)
Affinity DataKd:  1.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620518BDBM620518(N-(1-Hydroxy-4-(trifluoromethyl)-1,3-dihydrobenzo[...)
Affinity DataKd:  1.30E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620534BDBM620534(N-(1-Hydroxy-4-(methylsulfonyl)-1,3-dihydrobenzo[c...)
Affinity DataKd:  1.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620513BDBM620513((3-Borono-5-(3-borono-5-(trifluoromethyl)benzoyl)b...)
Affinity DataKd:  1.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620501BDBM620501(N-(5-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  1.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620511BDBM620511((S)-2,3-Bis(4-fluoro-1-hydroxy-1,3-dihydrobenzo[c]...)
Affinity DataKd:  1.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620514BDBM620514((3-Borono-5-((3-borono-5-(trifluoromethyl)phenyl)s...)
Affinity DataKd:  1.70E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620505BDBM620505(3-Borono-5-((3-borono-4-fluorophenyl)sulfonyl)-4-f...)
Affinity DataKd:  1.80E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620533BDBM620533((S)-2,3-Bis(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  2.00E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620516BDBM620516((3-Borono-5-(3-borono-5-fluorobenzoyl)benzoyl)glyc...)
Affinity DataKd:  2.00E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620527BDBM620527(2-((Bis(3-borono-5-(difluoromethyl)phenyl)(oxo)-&#...)
Affinity DataKd:  2.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620522BDBM620522(4-[(3R,4R)-3,4-bis[[1-hydroxy-4-(trifluoromethyl)-...)
Affinity DataKd:  2.30E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620529BDBM620529(2-((Bis(3-boronophenyl)(oxo)-λ6-sulfanylidene...)
Affinity DataKd:  2.30E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620532BDBM620532((3-Borono-5-((3-boronophenyl)sulfonyl)benzoyl)glyc...)
Affinity DataKd:  2.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620503BDBM620503(N-(6-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  2.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620498BDBM620498((S)-2,4-bis(4-borono-3-fluorobenzamido)butanoic ac...)
Affinity DataKd:  2.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620515BDBM620515(4-((3S,4S)-3,4-Bis(7-fluoro-1-hydroxy-1,3-dihydrob...)
Affinity DataKd:  2.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620497BDBM620497(N,N′-bis(4-borono-3-fluorobenzamido)-N-ethyl...)
Affinity DataKd:  2.70E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620502BDBM620502(N-(4-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  2.70E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620495BDBM620495(3,5-Bis((4-borono-2-fluorobenzamido)methyl)benzoic...)
Affinity DataKd:  3.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620504BDBM620504(N2,N6-Bis(6-fluoro-1-hydroxy-1,3-dihydrobenzo[c][1...)
Affinity DataKd:  3.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620525BDBM620525(N-(4-Chloro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  3.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620508BDBM620508(N6-(4-Borono-2-fluorobenzoyl)-N2-(6-fluoro-1-hydro...)
Affinity DataKd:  3.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620496BDBM620496(3,5-Bis((4-borono-3-fluorobenzamido)methyl)benzoic...)
Affinity DataKd:  3.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620531BDBM620531(2-((Bis(1-hydroxy-4-(trifluoromethyl)-1,3-dihydrob...)
Affinity DataKd:  3.70E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620507BDBM620507(3-Borono-5-(5-borono-2,4-difluorobenzoyl)benzoic a...)
Affinity DataKd:  4.00E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620530BDBM620530(N-(1-Hydroxy-5-(trifluoromethyl)-1,3-dihydrobenzo[...)
Affinity DataKd:  4.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620510BDBM620510((S)-2,3-Bis(5-fluoro-1-hydroxy-1,3-dihydrobenzo[c]...)
Affinity DataKd:  4.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620534BDBM620534(N-(1-Hydroxy-4-(methylsulfonyl)-1,3-dihydrobenzo[c...)
Affinity DataKd:  4.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620526BDBM620526((S)-3-(2,3-Bis(4-chloro-1-hydroxy-1,3-dihydrobenzo...)
Affinity DataKd:  4.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620496BDBM620496(3,5-Bis((4-borono-3-fluorobenzamido)methyl)benzoic...)
Affinity DataKd:  5.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620498BDBM620498((S)-2,4-bis(4-borono-3-fluorobenzamido)butanoic ac...)
Affinity DataKd:  6.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620495BDBM620495(3,5-Bis((4-borono-2-fluorobenzamido)methyl)benzoic...)
Affinity DataKd:  8.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620519BDBM620519((S)-2,3-Bis(1-hydroxy-4-(trifluoromethyl)-1,3-dihy...)
Affinity DataKd:  1.00E+7nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandChemical structure of BindingDB Monomer ID 620509BDBM620509((S)-2,3-Bis(7-fluoro-1-hydroxy-1,3-dihydrobenzo[c]...)
Affinity DataKd:  1.00E+7nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

Displayed 1 to 50 (of 79 total ) | Next | Last >>
Jump to: